Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2005
03/31/2005US20050070477 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease
03/31/2005US20050070473 administering parathyroid hormone; antiapoptotic agents; bone disorders
03/31/2005US20050070467 Antitumor agent
03/31/2005US20050070015 Methods of controlling proliferation of cancer cells and cell death
03/31/2005US20050069984 Identification of sortase gene
03/31/2005US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents
03/31/2005US20050069960 Which induce proliferation of tumor-infiltrating lymphocytes without systemic toxicity associated with the administration of wild-type cytokines; drug screening/design
03/31/2005US20050069946 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer
03/31/2005US20050069922 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus
03/31/2005US20050069919 Novel human secreted proteins and polynucleotides encoding the same
03/31/2005US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders.
03/31/2005US20050069598 Antidiabetic agents; moderate glucagon-like peptide; phosphoenolpyruvate carboxykinase inhbitors; weight control
03/31/2005US20050069596 Compositions and methods comprising kava and anti-anxiety compounds
03/31/2005US20050069595 Antiinflammatory agents; mixture with glucocorticoids; respiratory system disorders; antiarthritic agents
03/31/2005US20050069593 Synergistic mixtures; nutraceuticals
03/31/2005US20050069584 Diphenhydramine tannate solid dose compositions and methods of use
03/31/2005US20050069580 Compositions containing both sedative and non-sedative antihistamines and sleep aids
03/31/2005US20050069572 Multi-layered polymerizing hydrogels for tissue regeneration
03/31/2005US20050069569 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene
03/31/2005US20050069556 Serology display library; analyzing autologous tumor antigen; drug design; antitumor vaccine containing antigen
03/31/2005US20050069547 Binding protein; therapy for bone tumors
03/31/2005US20050069541 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
03/31/2005US20050069533 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
03/31/2005US20050069528 Mammalian endothelial cell model systems
03/31/2005US20050069527 Cell-based therapies for ischemia
03/31/2005US20050069522 Combination pharmaceutical agents as inhibitors of HCV replication
03/31/2005US20050069520 Methods and compositions for treating mammalian nerve tissue injuries
03/31/2005CA2676567A1 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
03/31/2005CA2540133A1 Drugs for treating cancer
03/31/2005CA2539741A1 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
03/31/2005CA2539377A1 Combinations of alpha-2-delta ligands and acetylcholinesterase inhibitors
03/31/2005CA2539361A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
03/31/2005CA2539320A1 Use of chk1 inhibitors to control cell proliferation
03/31/2005CA2539288A1 Thyroid hormone analogs and methods of use
03/31/2005CA2539230A1 Combinations of a vegf receptor inhibitor with other therapeutic agents
03/31/2005CA2538523A1 Treatment of gastrointestinal stromal tumors with imatinib and midostaurin
03/31/2005CA2538366A1 Concurrent drugs
03/31/2005CA2538284A1 Modulators of p-selectin glycoprotein ligand 1
03/31/2005CA2538064A1 Antibiotic product, use and formulation thereof
03/31/2005CA2537991A1 Combination of a vegf receptor inhibitor with a chemotherapeutic agent
03/31/2005CA2537989A1 Methods and reagents for the treatment of immunoinflammatory disorders
03/30/2005EP1518555A1 Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
03/30/2005EP1518549A1 A pellet comprising a local anesthetic agent and a radiopaque material
03/30/2005EP1517989A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
03/30/2005EP1517912A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
03/30/2005EP1517909A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517892A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
03/30/2005EP1517891A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
03/30/2005EP1517883A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
03/30/2005EP1517708A1 Combination treatment for depression and anxiety by nk1 and nk3 antagonists
03/30/2005EP1517707A1 Treatment for depression and anxiety with the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent
03/30/2005EP1517706A2 Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
03/30/2005EP1517705A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
03/30/2005EP1517697A1 Acidic insulin preparations with improved stability
03/30/2005EP1517695A2 Osteopontin, oligodendrocytes and myelination
03/30/2005EP1517691A1 Use of dopamine receptor agonists for the treatment of cutaneous tumors, warts, and scars
03/30/2005EP1517689A2 Selective analgesic agents
03/30/2005EP1517687A1 Medicament for the treatment of the systemic inflammatory response syndrome
03/30/2005EP1517686A2 Use of dantrolene, a ryanodine antagonist, in treating neural injury
03/30/2005EP1517682A1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
03/30/2005EP1517681A1 Peritoneal dialysate containing taurine
03/30/2005EP1517672A1 Compositions and methods for amelioration of human female sexual dysfunction
03/30/2005EP1517606A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
03/30/2005EP1429648A4 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER
03/30/2005EP1390037A4 Methods for treating delirium using glucocorticoid receptor-specific antagonists
03/30/2005EP1250132B1 Ibuprofen containing active agent preparation
03/30/2005EP1246692B1 Templating of uncharged solid particles by polymer multilayers
03/30/2005EP1227807B1 Irrigation solution and method for inhibition of pain and inflammation
03/30/2005EP1185294B1 Peptides for the treatment of impaired interpersonal and behavioral disorders
03/30/2005EP1183361B1 Gene therapy of pulmonary disease
03/30/2005EP1105378B1 Quinazoline derivatives
03/30/2005EP1076561B1 Combination therapy for the treatment of tumors
03/30/2005EP0804194B1 Use of retinoic acid receptor-agonists or ap-1 antagonists for the manufacture of a medicament for preventing proliferation of retinal pigment epithelium
03/30/2005EP0791056B1 Lipid-cleavage enzyme complex
03/30/2005CN1602360A Methods of increasing endogenous erythropoietin (EPO)
03/30/2005CN1602317A Angiopoietin-2 specific binding agents
03/30/2005CN1602308A Thiophene derivatives used as antiviral agent against flavivirus infections
03/30/2005CN1602216A Microprojection array immunization patch and method
03/30/2005CN1602207A Methods for inhibiting ocular processes
03/30/2005CN1602206A Pharmaceutical compositions based on azetidine derivatives
03/30/2005CN1602203A Use of gp130 activators in diabetic neuropathy
03/30/2005CN1602200A Plant extract active as an immunostimulating agent
03/30/2005CN1602195A Quinazoline derivatives for the treatment of abnormal cell growth
03/30/2005CN1602192A Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1602186A Prolonged release biodegradable microspheres and method for preparing same
03/30/2005CN1602172A Method and apparatus for the stimulation of hair growth
03/30/2005CN1600371A Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
03/30/2005CN1600370A New chemical medicine in small molecule in use for curing dysmenorrhea and ache of bad rheumatoid arthritis
03/30/2005CN1600300A Compound external remedy for treating psoriasis
03/30/2005CN1600296A Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets
03/30/2005CN1194692C Method of inhibiting skin damage of vitamin A analog
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872750 Modulating angiogenesis
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872724 Active polymorphs of 4-(2-(5- cyano-thiazol-2-ylamino) pyridin-4-ylmethyl)-piperazine-1-active polymorphs of 4-(2 5-cyano-thiazol-2-ylamino)-pyridin-4-ylmethyl)piperazine-1-carbo xylic acid methylamide which inhibit, regulate and/or modulate
1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 1151